This week, we will discuss the final results of the NEFIGARD trial with the GFR slope data. Is targeted release budesonide aka Nefecon really a way to provide steroid efficacy without steroid side effects?
This week, we tag along with NephMadness. It will be hard to stay impartial while discussing the role of angiogenic and antiangiogenic factors in severe preeclampsia prognosis.
This week, during kidney month and NephMadness season, we will discuss the USRDS report as well as the ISN Global Kidney Health Atlas report from 2024.
As expected - the renal denervation attracted a lot of attention. Beje did a super job hosting both the chats. And Sarah Gleeson accomplished the difficult task of curating those tweets into a coherent narrative!
Excellent chat always - providing an opportunity to learn for all of us. James Novak and Laura Slattery rose to the challenging job of hosting the chat and Divya did a great job curating the tweets!
Great chats - marking the NSMC take-over of NephJC. Visual Abstract by Sinead, NephJC hosting from Diana and Sinead, moments curated by Michelle Starr (with a bonus moment from Maryam Khosravi)
But lots of thoughtful discussion - including from people with experience of both systems, and across UK from Fergus Caskey who is doing an actual trial - check out the transcript and moments, from Maryam and Manasi.
Highlights being that the authors joined us for the first chat - and we had a surprise host, Maryam Khosravi making her debut with little planning and doing a fab job.